BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 33157387)

  • 1. Establishment of non-integrate induced pluripotent stem cell line CSUASOi006-A, from urine-derived cells of a PRPF8-related dominant retinitis pigmentosa patient.
    Zhou Y; Cui Z; Jing Y; Mao S; Chen D; Ding C; Gu J; Chan HF; Tang S; Chen J
    Stem Cell Res; 2020 Dec; 49():102041. PubMed ID: 33157387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of an induced pluripotent stem cell line (FRIMOi005-A) derived from a retinitis pigmentosa patient carrying a dominant mutation in RHO gene.
    Domingo-Prim J; Riera M; Burés-Jelstrup A; Corcostegui B; Pomares E
    Stem Cell Res; 2019 Jul; 38():101468. PubMed ID: 31146251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a human iPSC line from a patient with retinitis pigmentosa caused by mutation in PRPF8 gene.
    Lukovic D; Bolinches-Amorós A; Artero-Castro A; Pascual B; Carballo M; Hernan I; Erceg S
    Stem Cell Res; 2017 May; 21():23-25. PubMed ID: 28677533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of the induced pluripotent stem cell line SJTUGHi002-A from a CNGA1-related recessive retinitis pigmentosa patient.
    Wu Y; Zhang T; Chen Z; Tang L; Zhang L; Chen J; Wan X; Sun X
    Stem Cell Res; 2024 Apr; 76():103334. PubMed ID: 38340451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the pre-mRNA splicing-factor genes PRPF3, PRPF8, and PRPF31 in Spanish families with autosomal dominant retinitis pigmentosa.
    Martínez-Gimeno M; Gamundi MJ; Hernan I; Maseras M; Millá E; Ayuso C; García-Sandoval B; Beneyto M; Vilela C; Baiget M; Antiñolo G; Carballo M
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2171-7. PubMed ID: 12714658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermediate Uveitis in Retinitis Pigmentosa Associated with a Novel Homozygous Splice Site Mutation in
    Badawi AH; Magliyah MS; Schatz P; Al-Shehri A; Alabdullah AA
    Middle East Afr J Ophthalmol; 2022; 29(1):59-62. PubMed ID: 36685344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A).
    Ding Y; Carvalho E; Murphy C; McInerney V; Krawczyk J; O'Brien T; Howard L; Cai L; Shen S
    Stem Cell Res; 2020 Mar; 43():101665. PubMed ID: 31954326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of the human iPSC line CABi001-A from a patient with retinitis pigmentosa caused by a novel mutation in PRPF31 gene.
    de la Cerda B; Díez-Lloret A; Ponte B; Vallés-Saiz L; Calado SM; Rodríguez-Bocanegra E; Garcia-Delgado AB; Moya-Molina M; Bhattacharya SS; Díaz-Corrales FJ
    Stem Cell Res; 2019 Apr; 36():101426. PubMed ID: 30921587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of the induced pluripotent stem cell line IOCVi001-A from a patient with the MFRP-related retinitis pigmentosa-nanophthalmos syndrome.
    Mora-Roldan GA; Nava J; Gazarian K; Zenteno JC
    Stem Cell Res; 2024 Mar; 75():103309. PubMed ID: 38217995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and characterization of an iPSC line (FRIMOi001-A) derived from a retinitis pigmentosa patient carrying PDE6A mutations.
    Riera M; Patel A; Corcostegui B; Chang S; Sparrow JR; Pomares E; Corneo B
    Stem Cell Res; 2019 Mar; 35():101385. PubMed ID: 30685614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autosomal dominant retinitis pigmentosa-associated gene PRPF8 is essential for hypoxia-induced mitophagy through regulating ULK1 mRNA splicing.
    Xu G; Li T; Chen J; Li C; Zhao H; Yao C; Dong H; Wen K; Wang K; Zhao J; Xia Q; Zhou T; Zhang H; Gao P; Li A; Pan X
    Autophagy; 2018; 14(10):1818-1830. PubMed ID: 30103670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a human iPS cell line from a patient with retinitis pigmentosa due to EYS mutation.
    Calado SM; Garcia-Delgado AB; De la Cerda B; Ponte-Zuñiga B; Bhattacharya SS; Díaz-Corrales FJ
    Stem Cell Res; 2018 Dec; 33():251-254. PubMed ID: 30471616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of induced pluripotent stem cell line CSUASOi004-A by reprogramming peripheral blood mononuclear cells of a PRPF6-related dominant retinitis pigmentosa patient.
    Zhou Y; Jing Y; Mao S; Liu J; Cui Z; Wang Y; Chen J; Chan HF; Tang S; Chen J
    Stem Cell Res; 2020 May; 45():101793. PubMed ID: 32335390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of an induced pluripotent stem cell line (SJTUGHi001-A) from a patient with Retinitis Pigmentosa carrying c.77C > T mutation in RAX2 gene.
    Bai X; Chen J; Zhao X; Zhu X; Ding X; Zhang T; Jiang M; Sun X
    Stem Cell Res; 2024 Jun; 77():103390. PubMed ID: 38507880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of an induced pluripotent stem cell (iPSC) line from a patient with autosomal dominant retinitis pigmentosa due to a mutation in the NR2E3 gene.
    Terray A; Slembrouck A; Nanteau C; Chondroyer C; Zeitz C; Sahel JA; Audo I; Reichman S; Goureau O
    Stem Cell Res; 2017 Oct; 24():1-4. PubMed ID: 29034877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant Retinal Pigment Epithelial Cells Derived from Induced Pluripotent Stem Cells of a Retinitis Pigmentosa Patient with the PRPF6 Mutation.
    Liang Y; Tan F; Sun X; Cui Z; Gu J; Mao S; Chan HF; Tang S; Chen J
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of induced pluripotent stem cells to reveal pathogenic gene mutations and explore treatments for retinitis pigmentosa.
    Yoshida T; Ozawa Y; Suzuki K; Yuki K; Ohyama M; Akamatsu W; Matsuzaki Y; Shimmura S; Mitani K; Tsubota K; Okano H
    Mol Brain; 2014 Jun; 7():45. PubMed ID: 24935155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of induced pluripotent stem cell line CSUASOi003- A from an autosomal recessive retinitis pigmentosa patient carrying compound heterozygous mutations in CRB1 gene.
    Zhou Y; Ding C; Xia S; Jing Y; Mao S; Liu J; Chen J; Chan HF; Tang S; Chen J
    Stem Cell Res; 2020 Apr; 44():101742. PubMed ID: 32244200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis for splicing factor PRPF8 retinitis pigmentosa, novel mutations and correlation between human and yeast phenotypes.
    Towns KV; Kipioti A; Long V; McKibbin M; Maubaret C; Vaclavik V; Ehsani P; Springell K; Kamal M; Ramesar RS; Mackey DA; Moore AT; Mukhopadhyay R; Webster AR; Black GC; O'Sullivan J; Bhattacharya SS; Pierce EA; Beggs JD; Inglehearn CF
    Hum Mutat; 2010 May; 31(5):E1361-76. PubMed ID: 20232351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a gene-corrected human iPSC line (CSUASOi004-A-1) from a retinitis pigmentosa patient with heterozygous c.2699 G>A mutation in the PRPF6 gene.
    Liang Y; Sun X; Duan C; Zhou Y; Cui Z; Ding C; Gu J; Mao S; Ji S; Chan HF; Tang S; Chen J
    Stem Cell Res; 2022 Oct; 64():102911. PubMed ID: 36103774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.